PharmaTher Holdings Ltd. (CSE: PHRM)

Canada flag Canada · Delayed Price · Currency is CAD
0.220
+0.010 (4.76%)
Nov 22, 2024, 1:41 PM EST
62.96%
Market Cap 21.69M
Revenue (ttm) n/a
Net Income (ttm) -2.16M
Shares Out 88.52M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,000
Open 0.215
Previous Close 0.210
Day's Range 0.210 - 0.220
52-Week Range 0.140 - 0.430
Beta 3.39
Analysts n/a
Price Target n/a
Earnings Date Nov 5, 2024

About PharmaTher Holdings

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company’s product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson’s disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia and procedural sedation. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2019
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol PHRM
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.